Reckitt in $1.4bn settlement over US opioid treatment probe

Thursday 11th July 2019 13:45 BST


Consumer goods giant Reckitt Benckiser said it has agreed to pay up to $1.4bn to settle US investigations into the sale and marketing of an opioid addiction treatment by its former pharmaceuticals business Indivior.

The full article is no longer available.